Headlines about CVS Health (NYSE:CVS) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CVS Health earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media headlines about the pharmacy operator an impact score of 46.2954929363446 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the news stories that may have effected Accern’s analysis:

A number of brokerages recently issued reports on CVS. Needham & Company LLC upgraded CVS Health from a “buy” rating to a “strong-buy” rating and increased their target price for the stock from $88.00 to $100.00 in a report on Tuesday. ValuEngine lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Robert W. Baird reissued a “hold” rating and issued a $77.00 price target on shares of CVS Health in a research report on Friday, October 27th. Mizuho set a $90.00 price target on CVS Health and gave the company a “buy” rating in a research report on Tuesday, October 24th. Finally, Leerink Swann increased their price target on CVS Health from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Monday, January 8th. Two analysts have rated the stock with a sell rating, eight have given a hold rating, eleven have given a buy rating and three have issued a strong buy rating to the stock. CVS Health has a consensus rating of “Buy” and a consensus price target of $88.06.

Shares of CVS Health (NYSE CVS) traded down $4.44 on Tuesday, reaching $79.19. The company had a trading volume of 7,858,486 shares, compared to its average volume of 8,054,972. CVS Health has a 52 week low of $66.45 and a 52 week high of $84.00. The stock has a market cap of $79,720.00, a price-to-earnings ratio of 16.38, a P/E/G ratio of 1.29 and a beta of 0.90. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. During the same quarter last year, the firm posted $1.64 EPS. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. sell-side analysts predict that CVS Health will post 5.88 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a yield of 2.53%. CVS Health’s dividend payout ratio is currently 41.32%.

In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the firm’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the transaction, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.61% of the stock is owned by company insiders.

WARNING: This report was published by Marea Informative and is owned by of Marea Informative. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.mareainformativa.com/2018/01/30/cvs-health-cvs-receives-daily-news-sentiment-rating-of-0-16-updated-updated-updated.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Insider Buying and Selling by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.